Outlines the process for switching stable adult patients on ART from first line regimen TEE (Tenofovir +Emtricitabine + Efavirenz) to TLD (Tenofovir + Lamivudine + Dolutegravir) in the CCMDD programme and the process for registration of new patients into CCMDD with regards to TLD.
Person affected:
Health Facility staff
Authorised Prescribers
Patients
CCMDD service provider staff
Type
Standard Operating Procedure (SOP)
Topic
CCMDD
HIV/AIDS
Language
English
Publisher
National Department of Health
Copyright
Copyright Reserved
Year
2020
